Dihydrocaffeic acid (Synonyms: 3,4-Dihydroxy-benzenepropanoic acid)

Name: Dihydrocaffeic acid
Brand: MedChemExpress
SKU: HY-N2406
Rating: 5.0 (2 reviews)

Cat. No.: HY-N2406 Purity: 99.86%: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

Dihydrocaffeic acid is a microbial metabolite of flavonoids. Dihydrocaffeic acid scavenges intracellular ROS and increases nitric oxide synthase activity. Dihydrocaffeic acid reduces phosphorylation of MAPK p38 and prevent UVB-induced skin damage. Dihydrocaffeic acid has antioxidant, anti-inflammatory and anti-cartilage degradation activities.

For research use only. We do not sell to patients.

CAS No. : 1078-61-1

Size	Stock	Quantity

Free Sample (0.1 - 0.2 mg)	Apply Now
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	In-stock	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	In-stock	Estimated Time of Arrival: December 31
Solid
25 mg	In-stock	Estimated Time of Arrival: December 31
50 mg	In-stock	Estimated Time of Arrival: December 31
100 mg	In-stock	Estimated Time of Arrival: December 31
200 mg	Get quote
500 mg	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 2 publication(s) in Google Scholar

Other Forms of Dihydrocaffeic acid:

Dihydrocaffeic acid (Standard) In-stock

2 Publications Citing Use of MCE Dihydrocaffeic acid

Histological Imaging/Staining

ELISA

Cell Proliferation/Viability Assay

: Dihydrocaffeic acid purchased from MedChemExpress. Usage Cited in: Cell Commun Signal. 2025 Feb 5;23(1):65. [Abstract]; Dihydrocaffeic acid (DA) (low dose: 10 mg/kg; high dosen: 20 mg/kg) attenuated these injuries, and its protective effect was similar to that of the positive drug DEX by H&E staining.

: Dihydrocaffeic acid purchased from MedChemExpress. Usage Cited in: Cell Commun Signal. 2025 Feb 5;23(1):65. [Abstract]; The release of TNF-α, IL-1β and IL-6 in lung tissue treated with (low dose: 10 mg/kg; high dosen: 20 mg/kg).

: Dihydrocaffeic acid purchased from MedChemExpress. Usage Cited in: Cell Commun Signal. 2025 Feb 5;23(1):65. [Abstract]; Cytotoxicity assessment of Dihydrocaffeic acid (DA) (1, 5, 10, 50, 100, 200, 500 μM) and DA-P in cells.

: Dihydrocaffeic acid purchased from MedChemExpress. Usage Cited in: Cell Commun Signal. 2025 Feb 5;23(1):65. [Abstract]; Expression and densitometry analysis of inflammatory cytokines treated with Dihydrocaffeic acid (DA) (50, 100 μM).

: Dihydrocaffeic acid purchased from MedChemExpress. Usage Cited in: Cell Commun Signal. 2025 Feb 5;23(1):65. [Abstract]; Pull-down assay followed by western blot (up) and recombinant TALDO1 labeled by DA-P with Dihydrocaffeic acid (DA) (down).

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All p38 MAPK Isoform Specific Products:

View All Isoforms

p38 MAPK Akt1 p38α p38β MAPK13 p38δ p38γ

View All Endogenous Metabolite Isoform Specific Products:

View All Isoforms

Human Endogenous Metabolite Microbial Metabolite

View All NO Synthase Isoform Specific Products:

View All Isoforms

nNOS iNOS eNOS

Biological Activity
Purity & Documentation
References
Customer Review

Description

IC₅₀ & Target^[1]

Microbial Metabolite

p38 MAPK

Human Endogenous Metabolite

Cellular Effect

Cell Line	Type	Value	Description	References
HEp-2	CC₅₀	> 200 μg/mL Compound: 3	Cytotoxicity against human Hep2 cells after 24 hrs by MTT assay Cytotoxicity against human Hep2 cells after 24 hrs by MTT assay	[PMID: 26260341]
HFF-1	CC₅₀	> 200 μg/mL Compound: 3	Cytotoxicity against human HFF1 cells after 24 hrs by MTT assay Cytotoxicity against human HFF1 cells after 24 hrs by MTT assay	[PMID: 26260341]
Oocyte	IC₅₀	86.8 μM Compound: alpha,beta-diH-Caf-COOH, dihydrocaffeic acid	Antagonist activity at Gloeobacter violaceus ligand-gated ion channel expressed in Xenopus oocytes assessed as inhibition of MES buffer pH 5.5 -induced currents after 30 secs by voltage clamp technique Antagonist activity at Gloeobacter violaceus ligand-gated ion channel expressed in Xenopus oocytes assessed as inhibition of MES buffer pH 5.5 -induced currents after 30 secs by voltage clamp technique	[PMID: 23682762]
U-937	CC₅₀	> 2000 μM Compound: 20, DHCA	Cytotoxicity against human U937 cells after 48 hrs by trypan blue assay Cytotoxicity against human U937 cells after 48 hrs by trypan blue assay	[PMID: 22925447]
U-937	IC₅₀	212.7 μM Compound: 20, DHCA	Antiproliferative activity against human U937 cells assessed as incorporation of [3H]-methyl-thymidine after 12 hrs by scintillation counting Antiproliferative activity against human U937 cells assessed as incorporation of [3H]-methyl-thymidine after 12 hrs by scintillation counting	[PMID: 22925447]
Vero	CC₅₀	> 200 μg/mL Compound: 3	Cytotoxicity against African green monkey Vero cells after 24 hrs by MTT assay Cytotoxicity against African green monkey Vero cells after 24 hrs by MTT assay	[PMID: 26260341]

In Vitro

Dihydrocaffeic acid (24-96 h) shows cytotoxicity against human Hep2 and HFF1 cells, with CD₅₀s of >200 μg/mL^[2].
. Dihydrocaffeic acid (0.15 μM-2.0 mM) shows antiproliferative activity against human U937 cells, with IC₅₀ of 212.7 μM^[3].
. Dihydrocaffeic acid (16-24 h) shows antioxidant effects in human EA.hy926 endothelial cells^[4].
Dihydrocaffeic acid (25-100 μM, 24 h) reduces cytotoxicity and pro-inflammatory cytokine production (interleukin-6 and -8) in HaCaT cells, a keratinocyte model, following UV radiation^[5].
Dihydrocaffeic acid (40 μM, 24 h) improves IL-1β-induced inflammation and cartilage degradation in mouse OA chondrocytes via inhibiting NF-κB and MAPK signalling pathways^[6].
Dihydrocaffeic acid (10 μM) significantly decreases P-selectin expression in ADP-stimulated platelets^[7].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Dihydrocaffeic acid (3-30 mg/kg, i.p.) protects against ischemia-induced neuronal damage and cerebral edema in a rat model of focal cerebral ischemia^[8].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Molecular Weight

182.17

Formula

C₉H₁₀O₄

CAS No.

1078-61-1

Appearance

Solid

Color

Off-white to light brown

SMILES

O=C(O)CCC1=CC=C(O)C(O)=C1

Structure Classification

Ketones, Aldehydes, Acids

Initial Source

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Solvent & Solubility

In Vitro:

DMSO : 250 mg/mL (1372.34 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

H₂O : ≥ 100 mg/mL (548.94 mM)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	5.4894 mL	27.4469 mL	54.8938 mL
5 mM	1.0979 mL	5.4894 mL	10.9788 mL
10 mM	0.5489 mL	2.7447 mL	5.4894 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.08 mg/mL (11.42 mM); Clear solution

This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.08 mg/mL (11.42 mM); Clear solution

This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 2.08 mg/mL (11.42 mM); Clear solution

This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Calculation results:

Working solution concentration: mg/mL

This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact MedChemExpress (MCE).

Purity & Documentation

Purity: 99.86%

Select Batch:

Data Sheet (276 KB) SDS (394 KB)

COA (245 KB) HNMR (267 KB) RP-HPLC (253 KB) MS (68 KB)

Handling Instructions (2659 KB)

References

[1]. Oliveira MM, et al. Dihydrocaffeic Acid Prevents UVB-Induced Oxidative Stress Leading to the Inhibition of Apoptosis and MMP-1 Expression via p38 Signaling Pathway. Oxid Med Cell Longev. 2019 Jan 17;2019:2419096. [Content Brief]

[2]. Botta G, et al. Carbon nanotubes supported tyrosinase in the synthesis of lipophilic hydroxytyrosol and dihydrocaffeoyl catechols with antiviral activity against DNA and RNA viruses. Bioorg Med Chem. 2015 Sep 1;23(17):5345-51. [Content Brief]

[3]. Vázquez R, et al. Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action. Bioorg Med Chem. 2012 Sep 15;20(18):5537-49. [Content Brief]

[4]. Huang J, et al. Antioxidant effects of dihydrocaffeic acid in human EA.hy926 endothelial cells. J Nutr Biochem. 2004 Dec;15(12):722-9. [Content Brief]

[5]. Poquet L, et al. Effect of dihydrocaffeic acid on UV irradiation of human keratinocyte HaCaT cells. Arch Biochem Biophys. 2008 Aug 15;476(2):196-204. [Content Brief]

[6]. Lu R, et al. Dihydrocaffeic acid improves IL-1β-induced inflammation and cartilage degradation via inhibiting NF-κB and MAPK signalling pathways. Bone Joint Res. 2023 Apr 6;12(4):259-273. [Content Brief]

[7]. Baeza G, et al. The colonic metabolites dihydrocaffeic acid and dihydroferulic acid are more effective inhibitors of in vitro platelet activation than their phenolic precursors. Food Funct. 2017 Mar 22;8(3):1333-1342. [Content Brief]

[8]. Lee K, et al. Protective Effects of Dihydrocaffeic Acid, a Coffee Component Metabolite, on a Focal Cerebral Ischemia Rat Model. Molecules. 2015 Jun 30;20(7):11930-40. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

H₂O / DMSO	1 mM	5.4894 mL	27.4469 mL	54.8938 mL	137.2345 mL
	5 mM	1.0979 mL	5.4894 mL	10.9788 mL	27.4469 mL
	10 mM	0.5489 mL	2.7447 mL	5.4894 mL	13.7234 mL
	15 mM	0.3660 mL	1.8298 mL	3.6596 mL	9.1490 mL
	20 mM	0.2745 mL	1.3723 mL	2.7447 mL	6.8617 mL
	25 mM	0.2196 mL	1.0979 mL	2.1958 mL	5.4894 mL
	30 mM	0.1830 mL	0.9149 mL	1.8298 mL	4.5745 mL
	40 mM	0.1372 mL	0.6862 mL	1.3723 mL	3.4309 mL
	50 mM	0.1098 mL	0.5489 mL	1.0979 mL	2.7447 mL
	60 mM	0.0915 mL	0.4574 mL	0.9149 mL	2.2872 mL
	80 mM	0.0686 mL	0.3431 mL	0.6862 mL	1.7154 mL
	100 mM	0.0549 mL	0.2745 mL	0.5489 mL	1.3723 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

Dihydrocaffeic acid Related Classifications

Inflammation/Immunology

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Dihydrocaffeic acid1078-61-13,4-Dihydroxy-benzenepropanoic acidp38 MAPKEndogenous MetaboliteReactive Oxygen Species (ROS)NO SynthaseNitric oxide synthasesNOSMicrobial metaboliteAntioxidantAnti-inflammatory and Anti-cartilage DegradationHep2HFF1.Inhibitorinhibitorinhibit

Please select a local distributor ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Product Name			Requested Quantity *
Applicant Name *			Salutation
Email Address *			Phone Number *
Department			Organization Name *
City			State
Country or Region *
Remarks

Product Name			Lot #
Applicant Name *			Email Address *
Phone Number			Department *
Organization Name *			Country or Region *
Remarks

Name
Email *

	Sorry, but the email address you supplied was invalid.

Dihydrocaffeic acid (Synonyms: 3,4-Dihydroxy-benzenepropanoic acid)

Customer Review

Other Forms of Dihydrocaffeic acid:

Dihydrocaffeic acid Related Antibodies

2 Publications Citing Use of MCE Dihydrocaffeic acid

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All p38 MAPK Isoform Specific Products:

View All Endogenous Metabolite Isoform Specific Products:

View All NO Synthase Isoform Specific Products:

Biological Activity

Purity & Documentation

References

Customer Review

Dihydrocaffeic acid Related Antibodies

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Dihydrocaffeic acid Related Classifications

Keywords:

Your Recently Viewed Products:

Customer Review

Request for HNMR Report

SAFETY DATA SHEET (SDS)

Request for HNMR Report